These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19699192)

  • 1. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay.
    Dieplinger B; Januzzi JL; Steinmair M; Gabriel C; Poelz W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Nov; 409(1-2):33-40. PubMed ID: 19699192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasma.
    Dieplinger B; Egger M; Gegenhuber A; Haltmayer M; Mueller T
    Clin Chim Acta; 2015 Dec; 451(Pt B):310-5. PubMed ID: 26483129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of reference intervals for soluble ST2 from a United States population.
    Lu J; Snider JV; Grenache DG
    Clin Chim Acta; 2010 Nov; 411(21-22):1825-6. PubMed ID: 20654603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term stability of soluble ST2 in frozen plasma samples.
    Dieplinger B; Egger M; Poelz W; Haltmayer M; Mueller T
    Clin Biochem; 2010 Sep; 43(13-14):1169-70. PubMed ID: 20534378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.
    Mueller T; Dieplinger B
    Expert Rev Mol Diagn; 2013 Jan; 13(1):13-30. PubMed ID: 23256700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma.
    Dieplinger B; Egger M; Gabriel C; Poelz W; Morandell E; Seeber B; Kronenberg F; Haltmayer M; Mueller T; Dieplinger H
    Clin Chim Acta; 2013 Oct; 425():236-41. PubMed ID: 23981841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
    Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure.
    Broch K; Andreassen AK; Ueland T; Michelsen AE; Stueflotten W; Aukrust P; Aakhus S; Gullestad L
    Int J Cardiol; 2015 Jan; 179():378-84. PubMed ID: 25464491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble ST2 in heart failure.
    Dieplinger B; Mueller T
    Clin Chim Acta; 2015 Mar; 443():57-70. PubMed ID: 25269091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females.
    Dieplinger B; Egger M; Poelz W; Gabriel C; Haltmayer M; Mueller T
    Clin Chem Lab Med; 2011 Sep; 49(9):1515-8. PubMed ID: 21663467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble ST2--analytical considerations.
    Mueller T; Jaffe AS
    Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) study.
    Dieplinger B; Egger M; Koehler W; Firlinger F; Poelz W; Lenz K; Haltmayer M; Mueller T
    Clin Chim Acta; 2012 Mar; 413(5-6):587-93. PubMed ID: 22155704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of soluble ST2 levels in serum of HTLV-1 infected individuals.
    Zahedi Avval F; Shomali S; Nadri M; Boostani R; Jarahi L; Youssefi M
    Acta Microbiol Immunol Hung; 2015 Jun; 62(2):137-45. PubMed ID: 26132834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of plasma concentrations of soluble ST2 measured by three different commercially available assays: the MBL ST2 assay, the Presage ST2 assay, and the R&D ST2 assay.
    Mueller T; Zimmermann M; Dieplinger B; Ankersmit HJ; Haltmayer M
    Clin Chim Acta; 2012 Oct; 413(19-20):1493-4. PubMed ID: 22743282
    [No Abstract]   [Full Text] [Related]  

  • 15. Temporal changes of soluble ST2 after cardiovascular interventions.
    Willems S; Sels JW; Flier S; Versteeg D; Buhre WF; de Kleijn DP; Hoefer IE; Pasterkamp G
    Eur J Clin Invest; 2013 Feb; 43(2):113-20. PubMed ID: 23215810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble ST2 has a prognostic role in patients with suspected sepsis.
    Hur M; Kim H; Kim HJ; Yang HS; Magrini L; Marino R; Cardelli P; Di Somma S;
    Ann Lab Med; 2015 Nov; 35(6):570-7. PubMed ID: 26354344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation.
    Houghton-Triviño N; Salgado DM; Rodríguez JA; Bosch I; Castellanos JE
    J Gen Virol; 2010 Mar; 91(Pt 3):697-706. PubMed ID: 19889931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure.
    Mueller T; Dieplinger B; Gegenhuber A; Poelz W; Pacher R; Haltmayer M
    Clin Chem; 2008 Apr; 54(4):752-6. PubMed ID: 18375488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results.
    Wu AH; Wians F; Jaffe A
    Am Heart J; 2013 Jun; 165(6):995-9. PubMed ID: 23708172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel.
    Januzzi JL; Pascual-Figal D; Daniels LB
    Am J Cardiol; 2015 Apr; 115(7 Suppl):70B-5B. PubMed ID: 25670638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.